A comparison of cycle control, efficacy, and side effects among healthy Thai women between two low-dose oral contraceptives containing 20 microg ethinylestradio1/75 microg gestodene (Meliane) and 30 microg ethinylestradio1/75 microg gestodene (Gynera)
- PMID: 12499032
- DOI: 10.1016/s0010-7824(02)00411-0
A comparison of cycle control, efficacy, and side effects among healthy Thai women between two low-dose oral contraceptives containing 20 microg ethinylestradio1/75 microg gestodene (Meliane) and 30 microg ethinylestradio1/75 microg gestodene (Gynera)
Abstract
The purpose of this study was to compare cycle control, efficacy and side effects of an oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene, with a reference preparation containing 30 microg ethinylestradiol combined with 75 microg gestodene. From the study, it was demonstrated that the two regimens had no difference in cycle control, efficacy, and side effects. The occurrence of spotting and breakthrough bleeding was low and was not different between these two preparations. The most common adverse events in both treatment groups were nausea, vomiting, dizziness, and chloasma. There were no statistically significant change in body weight and blood pressure in both groups at the end of study. It is concluded that both preparations are good cycle control, reliable and low side effects oral contraceptives.
Copyright 2002 Elsevier Science Inc.
Similar articles
-
Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.Contraception. 1995 Apr;51(4):225-9. doi: 10.1016/0010-7824(95)00037-b. Contraception. 1995. PMID: 7796587 Clinical Trial.
-
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.Contraception. 1997 Mar;55(3):131-7. doi: 10.1016/s0010-7824(97)00025-5. Contraception. 1997. PMID: 9115000 Clinical Trial.
-
Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestrel.Contraception. 2001 Sep;64(3):201-7. doi: 10.1016/s0010-7824(01)00235-9. Contraception. 2001. PMID: 11704101 Clinical Trial.
-
Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations.Drugs. 1995 Aug;50(2):364-95. doi: 10.2165/00003495-199550020-00010. Drugs. 1995. PMID: 8521763 Review.
-
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].Minerva Ginecol. 2007 Aug;59(4):415-25. Minerva Ginecol. 2007. PMID: 17923832 Review. Italian.
Cited by
-
20 µg versus >20 µg estrogen combined oral contraceptives for contraception.Cochrane Database Syst Rev. 2013 Aug 1;2013(8):CD003989. doi: 10.1002/14651858.CD003989.pub5. Cochrane Database Syst Rev. 2013. PMID: 23904209 Free PMC article. Review.
-
Combination contraceptives: effects on weight.Cochrane Database Syst Rev. 2014 Jan 29;2014(1):CD003987. doi: 10.1002/14651858.CD003987.pub5. Cochrane Database Syst Rev. 2014. PMID: 24477630 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
